Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cells

Clinical and Experimental Immunology

Volumn 126, Issue 1, 2001, Pages 131-136

  Honda, S ^a,b   Migita, Kiyoshi ^a   Hirai, Y ^a   Origuchi, T ^a   Yamasaki, S ^a   Kamachi, M ^a   Shibatomi, K ^a   Fukuda, T ^b   Kita, M ^a   Hida, A ^a   Ida, H ^a   Aoyagi, T ^c   Kawakami, A ^a   Kawabe, Y ^a   Oizumi, K ^b   Eguchi, K ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Ureshino Medical Center   (Japan)

Author keywords

Interleukin 1; Membrane type matrix; Metalloproteinase; Rheumatoid arthritis; Synovium

Indexed keywords

CYTOKINE; ESONARIMOD; GELATINASE A; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MEMBRANE ENZYME; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; DEGRADATION; DESTRUCTION; DOWN REGULATION; DRUG EFFECT; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; ZYMOGRAPHY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; ENZYME PRECURSORS; GELATINASES; HUMANS; INTERLEUKIN-1; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; PHENYLPROPIONATES; RNA, MESSENGER; SYNOVIAL MEMBRANE; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANS-ACTIVATION (GENETICS);

EID: 0034771716     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01624.x     Document Type: Article

References (29)

1. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis
2. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization
3. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): Correlation with rheumatoid arthritis
4. Matrix metalloproteinase and their inhibitors in connective tissue remodeling
5. A matrix metalloproteinase expressed on the surface of invasive tumour cells
6. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase
7. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for progelatinase A activation
8. Matrix-degrading metalloproteinases and their roles in joint destruction
9. Differential expression of pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis
10. Expression of tissue localization of mambrane-types 1, 2 and 3 matrix metalloproteinases in rheumatoid synovium
11. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
12. Structure-activity studies of 3-benzoylpropionic acid derivatives suppressing adjuvant arthritis
13. Preparation and antirheumatic activity of optically active 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298)
14. Mechanisms of KE-298, 2-acetylthiomethyl-3-(4-methylbenzoyl) propionic acid, to suppress abnormal synovial cell functions in patients with rheumatoid arthritis
15. Suppressive effects of new antirheumatic drug KE-298 on TNF alpha-induced production of matrix metalloproteinase but not of tissue inhibitor-1 of metalloproteinase in human rheumatoid synoviocytes
16. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells
17. Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of bitu gelatinase A and its membrane-associated gelatinase A activator (MT-MMP)
18. Purification and characterization of a two-chain form of tissue inhibitor of metalloproteinases (TIMP) type 2 and a low molecular weight TIMP-like protein
19. Mechanism of cell surface activation of 72-kDa type 4 collagenase. Isolation of the activated form of the membrane metalloproteinase
20. Metalloproteinases and their inhibitors in matrix remodeling
21. Type IV collagenases in tumor invasion and metastasis
22. Expression of membrane type 1 matrix metalloproteinase in human arthritis cartilage
23. Expression of membrane-type 1 matrix metalloproteinase A in human osteoarthritic cartilage
24. Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells
25. Calcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation
26. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate
27. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas
28. Matrix matalloproteinases and tumor invasion: From correlation and causality to the clinic
29. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes